Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1544 USD | +4.60% | +10.29% | -20.82% |
15/04 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
05/03 | Transcript : CytoDyn Inc. - Special Call |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/23/03 |
Joseph Meidling
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Melissa Palmer
CTO | Chief Tech/Sci/R&D Officer | - | 24/23/24 |
Cyrus Arman
COO | Chief Operating Officer | 43 | 09/22/09 |
Chief Tech/Sci/R&D Officer | 59 | 01/20/01 | |
Cristina de Leon
IRC | Investor Relations Contact | - | - |
Tyler Blok
LAW | General Counsel | 37 | 25/22/25 |
Seenu Srinivasan
LAW | General Counsel | - | 07/21/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/22/13 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/22/24 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/22/01 |
Lishomwa Ndhlovu
BRD | Director/Board Member | 54 | 24/21/24 |
Tanya Urbach
CHM | Chairman | 57 | 24/21/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 9,000 | 0 | 0 | 99.15 % |
Stock B | 0 | 6,000 | 0 | 0 | |
Stock C | 0 | 19,000 | 0 | 0 | |
Stock D | 1 | 993,809,000 | 985,393,715 ( 99.15 %) | 443,000 ( 0.0446 %) |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-20.82% | 147M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- CYDY Stock
- Company CytoDyn Inc.